[시장보고서]판크레아틴 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

판크레아틴 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

Pancreatin Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

상품코드 : 1513691

리서치사 : Persistence Market Research

발행일 : 2024년 07월

페이지 정보 : 영문 288 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 6,901,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,079,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 11,737,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

Persistence Market Research는 최근 판크레아틴(Pancreatin) 세계 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 촉진요인, 동향, 기회 및 과제를 포함한 주요 시장 역학을 철저히 평가하고 시장 구조에 대한 심층적인 인사이트를 제공합니다.

주요 인사이트

판크레아틴 시장 규모(2024년) : 1억 1,942만 달러
시장 예측 금액(2032년) : 1억 8,390만 달러
세계 시장 성장률(2024-2032년 CAGR) : 5.5%

판크레아틴 시장 : 조사 범위

판크레아틴은 제약 및 의료 산업에서 중요한 역할을 하고 있으며, 주로 췌장 효소 결핍증 및 소화기 질환 치료에 사용됩니다. 돼지 또는 소의 췌장에서 추출되며 아밀라아제, 리파아제 및 프로테아제와 같은 소화 효소의 혼합물을 포함합니다. 판크레아틴 시장은 제약회사, 의료 서비스 제공자, 건강 보조 식품 제조업체를 고객으로 삼고 있으며 정제, 캡슐, 분말 등 다양한 제형을 제공하고 있습니다.

시장 성장 촉진요인:

세계 판크레아틴 시장은 만성 췌장염 및 낭포성섬유증과 같은 췌장 질환의 유병률 증가를 포함한 몇 가지 주요 요인에 의해 촉진되고 있습니다. 소화기 질환에 취약한 노인 인구의 증가와 효소 대체 요법에 대한 인식이 높아지면서 시장 확대에 기여하고 있습니다. 효소 추출 및 제형화 기술의 기술 발전은 제품의 효능과 환자 순응도를 높여 시장 성장을 촉진할 것입니다. 또한, 판크레아틴의 용도가 소화기 질환뿐만 아니라 치료용 영양제 및 대사성 질환의 효소 대체 요법으로 확대되고 있다는 점도 새로운 성장 기회를 제공하고 있습니다.

시장 억제요인:

유망한 성장 전망에도 불구하고, 판크레아틴 시장은 효소 제품에 대한 엄격한 규제 요건, 효소 활성 수준의 편차, 동물성 효소에 대한 윤리적 우려와 관련된 도전 과제에 직면해 있습니다. 각 지역의 안전 기준 및 제조 관행에 대한 규제 장벽은 시장 진입 장벽이자 제조업체의 운영 비용으로 작용할 수 있습니다. 또한, 효소대체요법에 대한 제한적인 보험급여 정책과 대체 치료제의 가용성은 특히 의료 인프라가 부족한 신흥국 시장에서 효소대체요법의 시장 침투를 가로막고 있습니다.

시장 기회:

생명공학 기술의 발전, 개인 맞춤형 의료 접근법, 효소 요법에 대한 연구 투자 증가로 인해 판크레아틴 시장은 큰 성장 기회를 맞이할 것으로 보입니다. 효소 대체 요법을 정밀 의료 및 유전자 검사와 통합하면 치료 결과와 환자 만족도를 향상시킬 수 있습니다. 또한, 전략적 파트너십, 의료 서비스 제공자와의 제휴, 신흥 시장 진출은 시장 기업이 제품 포트폴리오를 확장하고 시장 입지를 강화할 수 있는 길을 제공합니다.

본 보고서에서 다루는 주요 질문들

세계 판크레아틴 시장의 성장을 촉진하는 주요 요인은 무엇인가?
제약 및 헬스케어 분야에서 판크레아틴의 채택을 촉진하는 제형과 용도는 무엇인가?
기술 발전은 어떻게 판크레아틴 시장의 경쟁 구도를 재편하고 있는가?
판크레아틴 시장에 기여하는 주요 기업은 어디에 있으며, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
세계 판크레아틴 시장의 새로운 트렌드와 향후 전망은?

소비자 감정 분석
- 소비자 감정 분석 - 종합적인 식품 보충제 소비
- 소비자 감정 분석 - 연령과 성별로 본 인기 보충제
- 소비자 감정 분석 - 식품 보충제 카테고리
소셜 미디어 감정 분석
- 소셜 미디어 감정 분석 - 지역별 관심도 " 췌장"
- 소셜 미디어 감정 분석 - 췌장 효소
- 소셜 미디어 감정 분석 - 효소
- 소셜 미디어 감정 분석 - 췌장 효소 Vs 효소

제7장 특허 분석

특허 분석 - 판크레아틴, 2019-2023년
특허 분석 - 판크레아틴 법적 지위, 2019-2023년
특허 분석 - 판크레아틴 특허 문서 : 유형별, 2019-2023년

제8장 세계의 판크레아틴 시장 수요량(톤) 분석

과거 시장 규모(톤) 분석, 2019-2023년
현재 및 향후 시장 수량(톤) 예측, 2024-2032년

제9장 세계의 판크레아틴 시장 - 가격 분석

지역별 가격 분석

제10장 세계의 판크레아틴 시장 수요액 분석

과거 시장 금액 분석, 2019-2023년
현재 및 향후 시장 금액 예측, 2024-2032년
- 전년비 성장 동향 분석
- 절대액 기회 분석

제11장 시장 배경

거시경제 요인
COVID-19가 효소 시장에 미치는 영향
COVID-19리스크 평가/영향
세계의 효소 산업 전망
세계의 제약 업계 전망
세계의 뉴트라슈티컬 산업 전망
최종 이용 업계 수요 분석
판크레아틴 처리 기술
업계 가치와 공급망 분석
주요 인증/주장
주요 규제
시장 역학
예측요인 - 관련성과 영향

제12장 세계의 판크레아틴 시장 분석 : 형태별

소개/주요 조사 결과
과거 시장 금액과 수량(톤) 분석 : 형태별, 2019-2023년
현재 및 향후 시장 금액과 수량(톤) 분석과 예측 : 형태별, 2024-2032년
- 분말
- 펠릿
시장 매력 분석 : 형태별

제13장 세계의 판크레아틴 시장 분석 : 유래별

소개/주요 조사 결과
과거 시장 금액과 수량(톤) 분석 : 유래별, 2019-2023년
현재 및 향후 시장 금액과 수량(톤) 분석과 예측 : 유래별, 2024-2032년
- 돼지
- 소
시장 매력 분석 : 유래별

제14장 세계의 판크레아틴 시장 분석 : 용도별

소개/주요 조사 결과
과거 시장 금액과 수량(톤) 분석 : 용도별, 2019-2023년
현재 및 향후 시장 금액과 수량(톤) 분석과 예측 : 용도별, 2024-2032년
- 제약
- 뉴트라슈티컬
시장 매력 분석 : 용도별

제15장 세계의 판크레아틴 시장 분석 : 지역별

소개
과거 시장 금액과 수량(톤) 분석 : 지역별, 2019-2023년
현재 시장 금액과 수량(톤) 분석과 예측 : 지역별, 2024-2032년
- 북미
- 라틴아메리카
- 유럽
- 동아시아
- 남아시아
- 오세아니아
- 중동 및 아프리카(MEA)
시장 매력 분석 : 지역별

제16장 북미의 판크레아틴 시장 분석

제17장 라틴아메리카의 판크레아틴 시장 분석

제18장 유럽의 판크레아틴 시장 분석

제19장 남아시아의 판크레아틴 시장 분석

제20장 동아시아의 판크레아틴 시장 분석

제21장 오세아니아의 판크레아틴 시장 분석

제22장 중동 및 아프리카의 판크레아틴 시장 분석

제23장 국가별 판크레아틴 시장 분석, 2024년

소개
미국
캐나다
브라질
멕시코
독일
이탈리아
프랑스
영국
스페인
러시아
폴란드
중국
일본
한국
인도
태국
인도네시아
말레이시아
호주
뉴질랜드
남아프리카공화국

제24장 시장 구조 분석

시장 분석 : 기업 계층별
주요 기업의 시장 점유율 분석
시장 입지 분석

제25장 시장 구조 분석

시장 분석 : 기업 계층별
시장 집중
시장 입지 분석

제26장 경쟁 분석

경쟁 대시보드
경쟁 상세 정보
- Antozyme Biotech Pvt Ltd
- Umang Pharmaceuticals
- Enzyme Bioscience Pvt. Ltd
- Biovencer Healthcare Private Limited
- Nordmark
- Fengchen Group Co., Ltd.
- Biozyme
- Sichuan Biosyn Pharmaceutical Co., Ltd.
- Bioseutica
- Wellona Pharma
- Shreeji Pharma International
- Hetero Healthcare Limited
- Creative Enzymes
- Baoding Faithful Industry Co. Ltd.
- SG Pharma Pvt. Ltd.
- Provita Nutrition and Health Inc.
- Hepalink Group
- NOW(R) Foods
- Bio Basic Inc.
- Sichuan Deebio Pharmaceutical Co., Ltd.
- 기타(요청시 추가 제공)

제27장 사용되는 가정과 두문자어

제28장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for pancreatin. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Pancreatin Market Size (2024E): USD 119.42 million
Projected Market Value (2032F): USD 183.90 million
Global Market Growth Rate (CAGR 2024 to 2032): 5.5%

Pancreatin Market - Report Scope:

Pancreatin plays a vital role in the pharmaceutical and healthcare industries, primarily used in the treatment of pancreatic enzyme deficiencies and digestive disorders. It is derived from porcine or bovine pancreas and contains a mixture of digestive enzymes such as amylase, lipase, and protease. The pancreatin market serves pharmaceutical companies, healthcare providers, and dietary supplement manufacturers, offering a range of formulations including tablets, capsules, and powders.

Market Growth Drivers:

The global pancreatin market is driven by several key factors, including the increasing prevalence of pancreatic disorders such as chronic pancreatitis and cystic fibrosis. Growing geriatric population prone to digestive ailments and rising awareness about enzyme replacement therapies contribute to market expansion. Technological advancements in enzyme extraction and formulation techniques enhance product efficacy and patient compliance, fostering market growth. Moreover, the expanding application of pancreatin beyond digestive disorders into therapeutic nutrition and enzyme replacement therapies for metabolic conditions presents new growth opportunities.

Market Restraints:

Despite promising growth prospects, the pancreatin market faces challenges related to stringent regulatory requirements for enzyme products, variability in enzyme activity levels, and ethical concerns regarding animal-derived enzymes. Regulatory hurdles in different regions regarding safety standards and manufacturing practices pose barriers to market entry and operational costs for manufacturers. Furthermore, limited reimbursement policies for enzyme replacement therapies and the availability of alternative treatments constrain market penetration, particularly in developing regions with limited healthcare infrastructure.

Market Opportunities:

The pancreatin market presents significant growth opportunities driven by advancements in biotechnology, personalized medicine approaches, and increasing research investments in enzyme therapies. The integration of enzyme replacement therapies with precision medicine and genetic testing enhances treatment outcomes and patient satisfaction. Furthermore, strategic partnerships, collaborations with healthcare providers, and expansion into emerging markets offer avenues for market players to broaden their product portfolios and strengthen market presence.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the pancreatin market globally?
Which formulations and applications are driving pancreatin adoption across pharmaceutical and healthcare sectors?
How are technological advancements reshaping the competitive landscape of the pancreatin market?
Who are the key players contributing to the pancreatin market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global pancreatin market?

Competitive Intelligence and Business Strategy:

Leading players in the global pancreatin market, including Nordmark,Bioseutica,Wellona Pharma, focus on innovation, product differentiation, and strategic acquisitions to gain a competitive edge. These companies invest in research and development to improve enzyme extraction methods, develop novel formulations, and expand their geographic footprint. Collaborations with academic institutions, healthcare providers, and regulatory agencies facilitate market access and compliance with international standards. Moreover, emphasis on patient education, clinical trials, and adherence to evidence-based practices supports market growth and enhances therapeutic outcomes in the evolving pancreatin landscape.

Key Companies Profiled:

Biovencer Healthcare Private Limited
Nordmark
Fengchen Group Co., Ltd.
Biozyme
Sichuan Biosyn Pharmaceutical Co., Ltd.
Bioseutica
Wellona Pharma
Shreeji Pharma International
Hetero Healthcare Limited
Creative Enzymes
Baoding Faithful Industry Co. Ltd.
SG Pharma Pvt. Ltd.
Provita Nutrition and Health Inc.
Hepalink Group
NOW(R) Foods
Bio Basic Inc.
Sichuan Deebio Pharmaceutical Co., Ltd.
Enzyme Bioscience Pvt. Ltd

Pancreatin Industry Research by Category

By Form:

Powder
Pellets

By Source:

Porcine
Bovine

By Application:

Pharmaceuticals
Nutraceuticals

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Strategic Promotional Strategies

5. Trade Outlook Scenario

5.1. Top Importing Countries (Value & Volume Analysis)
5.2. Top Exporting Countries (Value & Volume Analysis)
5.3. Average Pricing of Exporters & Importers

6. Sentiment Analysis

6.1. Consumer Sentiment Analysis
- 6.1.1. Consumer Sentiment Analysis - Overall Food Supplement Consumption
- 6.1.2. Consumer Sentiment Analysis - Popular Supplements Mapped by Age & Gender
- 6.1.3. Consumer Sentiment Analysis - Food Supplement Categories
6.2. Social Media Sentiment Analysis
- 6.2.1. Social Media Sentiment Analysis - Interest by Region "Pancreatin"
  - 6.2.1.1. Social Media Sentiment Analysis - "Pancreatin" Interest by Country
  - 6.2.1.2. Social Media Sentiment Analysis - "Pancreatin" Related Topics
  - 6.2.1.3. Social Media Sentiment Analysis - "Pancreatin" Related Queries
- 6.2.2. Social Media Sentiment Analysis - Pancreatic Enzymes
  - 6.2.2.1. Social Media Sentiment Analysis - Interest by Region "Pancreatic Enzyme"
  - 6.2.2.2. Social Media Sentiment Analysis - "Pancreatic Enzyme" Interest by Country
- 6.2.3. Social Media Sentiment Analysis - Enzymes
  - 6.2.3.1. Social Media Sentiment Analysis - Interest by Region "Enzyme"
  - 6.2.3.2. Social Media Sentiment Analysis - "Enzyme" Interest by Country
- 6.2.4. Social Media Sentiment Analysis - Pancreatic Enzymes Vs Enzymes

7. Patent Analysis

7.1. Patent Analysis - Pancreatin 2019-2023
7.2. Patent Analysis - Pancreatin Legal Status 2019-2023
7.3. Patent Analysis - Pancreatin Patented Documents by Type 2019-2023

8. Global Pancreatin Market Demand Volume (Tons) Analysis 2019-2023 and Forecast, 2024-2032

8.1. Historical Market Volume ( Tons) Analysis, 2019-2023
8.2. Current and Future Market Volume (Tons) Projections, 2024-2032

9. Global Pancreatin Market - Pricing Analysis

9.1. Regional Pricing Analysis

10. Global Pancreatin Market Demand Value (US$ '000) Analysis 2019-2023 and Forecast, 2024-2032

10.1. Historical Market Value (US$ '000) Analysis, 2019-2023
10.2. Current and Future Market Value (US$ '000) Projections, 2024-2032
- 10.2.1. Y-o-Y Growth Trend Analysis
- 10.2.2. Absolute $ Opportunity Analysis

11. Market Background

11.1. Macro-Economic Factors
- 11.1.1. Global GDP Growth Outlook
- 11.1.2. Global Industry Value Added
- 11.1.3. Global Urbanization Growth Outlook
- 11.1.4. Global Food Security Index Outlook
- 11.1.5. Global Rank - Ease of Doing Business
- 11.1.6. Global Rank - Trading Across Borders
11.2. Impact of COVID-19 on Enzymes Market
- 11.2.1. Manufacturer/Processors
- 11.2.2. Supply Chain and Logistics
- 11.2.3. Wholesalers/Traders
- 11.2.4. Retailers
11.3. COVID-19 Risk Assessment/Impact
11.4. Global Enzyme Industry Outlook
11.5. Global Pharmaceutical Industry Outlook
11.6. Global Nutraceutical Industry Outlook
11.7. End User Industry Demand Analysis
11.8. Pancreatin Processing Technology
11.9. Industry Value and Supply Chain Analysis
- 11.9.1. Profit Margin Analysis at each point of sales
  - 11.9.1.1. Pancreatin Market Processors
  - 11.9.1.2. Distributors/Suppliers/Wholesalers
  - 11.9.1.3. Traders/Retailers
  - 11.9.1.4. End Users
11.10. Key Certifications/Claims
11.11. Key Regulations
11.12. Market Dynamics
- 11.12.1. Drivers
- 11.12.2. Restraints
- 11.12.3. Opportunity Analysis
11.13. Forecast Factors - Relevance & Impact

12. Global Pancreatin Market Analysis 2019-2023 and Forecast 2024-2032, By Form

12.1. Introduction / Key Findings
12.2. Historical Market Value (US$ '000) and Volume (in Tons) Analysis By Form, 2019-2023
12.3. Current and Future Market Value (US$ '000) and Volume (in Tons) Analysis and Forecast By Form, 2024-2032
- 12.3.1. Powder
- 12.3.2. Pellets
12.4. Market Attractiveness Analysis By Form

13. Global Pancreatin Market Analysis 2019-2023 and Forecast 2024-2032, By Source

13.1. Introduction / Key Findings
13.2. Historical Market Value (US$ '000) and Volume (in Tons) Analysis By Source, 2019-2023
13.3. Current and Future Market Value (US$ '000) and Volume (in Tons) Analysis and Forecast By Source, 2024-2032
- 13.3.1. Porcine
- 13.3.2. Bovine
13.4. Market Attractiveness Analysis By Source

14. Global Pancreatin Market Analysis 2019-2023 and Forecast 2024-2032, By Application

14.1. Introduction / Key Findings
14.2. Historical Market Value (US$ '000) and Volume (in Tons) Analysis By Application, 2019-2023
14.3. Current and Future Market Value (US$ '000) and Volume (in Tons) Analysis and Forecast By Application, 2024-2032
- 14.3.1. Pharmaceutical
- 14.3.2. Nutraceutical
14.4. Market Attractiveness Analysis By Application

15. Global Pancreatin Market Analysis 2019-2023 and Forecast 2024-2032, by Region

15.1. Introduction
15.2. Historical Market Value (US$ '000) and Volume (in Tons) Analysis By Region, 2019-2023
15.3. Current Market Value (US$ '000) and Volume (in Tons) Analysis and Forecast By Region, 2024-2032
- 15.3.1. North America
- 15.3.2. Latin America
- 15.3.3. Europe
- 15.3.4. East Asia
- 15.3.5. South Asia
- 15.3.6. Oceania
- 15.3.7. Middle East and Africa (MEA)
15.4. Market Attractiveness Analysis By Region

16. North America Pancreatin Market Analysis 2019-2023 and Forecast 2024-2032

16.1. Introduction
16.2. Historical Market Value (US$ '000) and Volume (in Tons) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Market Value (US$ '000) and Volume (in Tons) Forecast By Market Taxonomy, 2024-2032
- 16.3.1. By Country
  - 16.3.1.1. U.S.
  - 16.3.1.2. Canada
- 16.3.2. By Form
- 16.3.3. By Source
- 16.3.4. By Application
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Form
- 16.4.3. By Source
- 16.4.4. By Application
16.5. Drivers and Restraints - Impact Analysis

17. Latin America Pancreatin Market Analysis 2019-2023 and Forecast 2024-2032

17.1. Introduction
17.2. Historical Market Value (US$ '000) and Volume (in Tons) Trend Analysis By Market Taxonomy, 2019-2023
17.3. Market Value (US$ '000) and Volume (in Tons) Forecast By Market Taxonomy, 2024-2032
- 17.3.1. By Country
  - 17.3.1.1. Brazil
  - 17.3.1.2. Mexico
  - 17.3.1.3. Rest of Latin America
- 17.3.2. By Form
- 17.3.3. By Source
- 17.3.4. By Application
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Form
- 17.4.3. By Source
- 17.4.4. By Application
17.5. Drivers and Restraints - Impact Analysis

18. Europe Pancreatin Market Analysis 2019-2023 and Forecast 2024-2032

18.1. Introduction
18.2. Historical Market Value (US$ '000) and Volume (in Tons) Trend Analysis By Market Taxonomy, 2019-2023
18.3. Market Value (US$ '000) and Volume (in Tons) Forecast By Market Taxonomy, 2024-2032
- 18.3.1. By Country
  - 18.3.1.1. Germany
  - 18.3.1.2. U.K.
  - 18.3.1.3. France
  - 18.3.1.4. Italy
  - 18.3.1.5. Spain
  - 18.3.1.6. BENELUX
  - 18.3.1.7. Nordic
  - 18.3.1.8. Russia
  - 18.3.1.9. Poland
  - 18.3.1.10. Rest of Europe
- 18.3.2. By Form
- 18.3.3. By Source
- 18.3.4. By Application
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Form
- 18.4.3. By Source
- 18.4.4. By Application
18.5. Drivers and Restraints - Impact Analysis

19. South Asia Pancreatin Market Analysis 2019-2023 and Forecast 2024-2032

19.1. Introduction
19.2. Historical Market Value (US$ '000) and Volume (in Tons) Trend Analysis By Market Taxonomy, 2019-2023
19.3. Market Value (US$ '000) and Volume (in Tons) Forecast By Market Taxonomy, 2024-2032
- 19.3.1. By Country
  - 19.3.1.1. India
  - 19.3.1.2. Thailand
  - 19.3.1.3. Indonesia
  - 19.3.1.4. Malaysia
  - 19.3.1.5. Rest of South Asia
- 19.3.2. By Form
- 19.3.3. By Source
- 19.3.4. By Application
19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Form
- 19.4.3. By Source
- 19.4.4. By Application
19.5. Drivers and Restraints - Impact Analysis

20. East Asia Pancreatin Market Analysis 2019-2023 and Forecast 2024-2032

20.1. Introduction
20.2. Historical Market Value (US$ '000) and Volume (in Tons) Trend Analysis By Market Taxonomy, 2019-2023
20.3. Market Value (US$ '000) and Volume (in Tons) Forecast By Market Taxonomy, 2024-2032
- 20.3.1. By Country
  - 20.3.1.1. China
  - 20.3.1.2. Japan
  - 20.3.1.3. South Korea
- 20.3.2. By Form
- 20.3.3. By Source
- 20.3.4. By Application
20.4. Market Attractiveness Analysis
- 20.4.1. By Country
- 20.4.2. By Form
- 20.4.3. By Source
- 20.4.4. By Application
20.5. Drivers and Restraints - Impact Analysis

21. Oceania Pancreatin Market Analysis 2019-2023 and Forecast 2024-2032

21.1. Introduction
21.2. Historical Market Value (US$ '000) and Volume (in Tons) Trend Analysis By Market Taxonomy, 2019-2023
21.3. Market Value (US$ '000) and Volume (in Tons) Forecast By Market Taxonomy, 2024-2032
- 21.3.1. By Country
  - 21.3.1.1. Australia
  - 21.3.1.2. New Zealand
- 21.3.2. By Form
- 21.3.3. By Source
- 21.3.4. By Application
21.4. Market Attractiveness Analysis
- 21.4.1. By Country
- 21.4.2. By Form
- 21.4.3. By Source
- 21.4.4. By Application
21.5. Drivers and Restraints - Impact Analysis

22. Middle East and Africa Pancreatin Market Analysis 2019-2023 and Forecast 2024-2032

22.1. Introduction
22.2. Historical Market Value (US$ '000) and Volume (in Tons) Trend Analysis By Market Taxonomy, 2019-2023
22.3. Market Value (US$ '000) and Volume (in Tons) Forecast By Market Taxonomy, 2024-2032
- 22.3.1. By Country
  - 22.3.1.1. GCC Countries
  - 22.3.1.2. South Africa
  - 22.3.1.3. Rest of Middle East and Africa
- 22.3.2. By Form
- 22.3.3. By Source
- 22.3.4. By Application
22.4. Market Attractiveness Analysis
- 22.4.1. By Country
- 22.4.2. By Form
- 22.4.3. By Source
- 22.4.4. By Application
22.5. Drivers and Restraints - Impact Analysis

23. Country Wise Pancreatin Market Analysis 2024

23.1. Introduction
- 23.1.1. Market Value Proportion Analysis, By Key Countries
- 23.1.2. Global Vs. Country Growth Comparison
23.2. U.S. Pancreatin Market Analysis
- 23.2.1. By Form
- 23.2.2. By Source
- 23.2.3. By Application
23.3. Canada Pancreatin Market Analysis
- 23.3.1. By Form
- 23.3.2. By Source
- 23.3.3. By Application
23.4. Brazil Pancreatin Market Analysis
- 23.4.1. By Form
- 23.4.2. By Source
- 23.4.3. By Application
23.5. Mexico Pancreatin Market Analysis
- 23.5.1. By Form
- 23.5.2. By Source
- 23.5.3. By Application
23.6. Germany Pancreatin Market Analysis
- 23.6.1. By Form
- 23.6.2. By Source
- 23.6.3. By Application
23.7. Italy Pancreatin Market Analysis
- 23.7.1. By Form
- 23.7.2. By Source
- 23.7.3. By Application
23.8. France Pancreatin Market Analysis
- 23.8.1. By Form
- 23.8.2. By Source
- 23.8.3. By Application
23.9. U.K. Pancreatin Market Analysis
- 23.9.1. By Form
- 23.9.2. By Source
- 23.9.3. By Application
23.10. Spain Pancreatin Market Analysis
- 23.10.1. By Form
- 23.10.2. By Source
- 23.10.3. By Application
23.11. Russia Pancreatin Market Analysis
- 23.11.1. By Form
- 23.11.2. By Source
- 23.11.3. By Application
23.12. Poland Pancreatin Market Analysis
- 23.12.1. By Form
- 23.12.2. By Source
- 23.12.3. By Application
23.13. China Pancreatin Market Analysis
- 23.13.1. By Form
- 23.13.2. By Source
- 23.13.3. By Application
23.14. Japan Pancreatin Market Analysis
- 23.14.1. By Form
- 23.14.2. By Source
- 23.14.3. By Application
23.15. S. Korea Pancreatin Market Analysis
- 23.15.1. By Form
- 23.15.2. By Source
- 23.15.3. By Application
23.16. India Pancreatin Market Analysis
- 23.16.1. By Form
- 23.16.2. By Source
- 23.16.3. By Application
23.17. Thailand Pancreatin Market Analysis
- 23.17.1. By Form
- 23.17.2. By Source
- 23.17.3. By Application
23.18. Indonesia Pancreatin Market Analysis
- 23.18.1. By Form
- 23.18.2. By Source
- 23.18.3. By Application
23.19. Malaysia Pancreatin Market Analysis
- 23.19.1. By Form
- 23.19.2. By Source
- 23.19.3. By Application
23.20. Australia Pancreatin Market Analysis
- 23.20.1. By Form
- 23.20.2. By Source
- 23.20.3. By Application
23.21. New Zealand Pancreatin Market Analysis
- 23.21.1. By Form
- 23.21.2. By Source
- 23.21.3. By Application
23.22. South Africa Pancreatin Market Analysis
- 23.22.1. By Form
- 23.22.2. By Source
- 23.22.3. By Application

24. Market Structure Analysis

24.1. Market Analysis by Tier of Companies
24.2. Market Share Analysis of Top Players
24.3. Market Presence Analysis

25. Market Structure Analysis

25.1. Market Analysis by Tier of Companies
25.2. Market Concentration
25.3. Market Presence Analysis

26. Competition Analysis

26.1. Competition Dashboard
26.2. Competition Deep Dive
- 26.2.1. Antozyme Biotech Pvt Ltd
  - 26.2.1.1. Overview
  - 26.2.1.2. Product Portfolio
  - 26.2.1.3. Sales Footprint
  - 26.2.1.4. Key Developments
  - 26.2.1.5. Strategy Overview
- 26.2.2. Umang Pharmaceuticals
  - 26.2.2.1. Overview
  - 26.2.2.2. Product Portfolio
  - 26.2.2.3. Sales Footprint
  - 26.2.2.4. Key Developments
  - 26.2.2.5. Strategy Overview
- 26.2.3. Enzyme Bioscience Pvt. Ltd
  - 26.2.3.1. Overview
  - 26.2.3.2. Product Portfolio
  - 26.2.3.3. Sales Footprint
  - 26.2.3.4. Key Developments
  - 26.2.3.5. Strategy Overview
- 26.2.4. Biovencer Healthcare Private Limited
  - 26.2.4.1. Overview
  - 26.2.4.2. Product Portfolio
  - 26.2.4.3. Sales Footprint
  - 26.2.4.4. Key Developments
  - 26.2.4.5. Strategy Overview
- 26.2.5. Nordmark
  - 26.2.5.1. Overview
  - 26.2.5.2. Product Portfolio
  - 26.2.5.3. Sales Footprint
  - 26.2.5.4. Key Developments
  - 26.2.5.5. Strategy Overview
- 26.2.6. Fengchen Group Co., Ltd.
  - 26.2.6.1. Overview
  - 26.2.6.2. Product Portfolio
  - 26.2.6.3. Sales Footprint
  - 26.2.6.4. Key Developments
  - 26.2.6.5. Strategy Overview
- 26.2.7. Biozyme
  - 26.2.7.1. Overview
  - 26.2.7.2. Product Portfolio
  - 26.2.7.3. Sales Footprint
  - 26.2.7.4. Key Developments
  - 26.2.7.5. Strategy Overview
- 26.2.8. Sichuan Biosyn Pharmaceutical Co., Ltd.
  - 26.2.8.1. Overview
  - 26.2.8.2. Product Portfolio
  - 26.2.8.3. Sales Footprint
  - 26.2.8.4. Key Developments
  - 26.2.8.5. Strategy Overview
- 26.2.9. Bioseutica
  - 26.2.9.1. Overview
  - 26.2.9.2. Product Portfolio
  - 26.2.9.3. Sales Footprint
  - 26.2.9.4. Key Developments
  - 26.2.9.5. Strategy Overview
- 26.2.10. Wellona Pharma
  - 26.2.10.1. Overview
  - 26.2.10.2. Product Portfolio
  - 26.2.10.3. Sales Footprint
  - 26.2.10.4. Key Developments
  - 26.2.10.5. Strategy Overview
- 26.2.11. Shreeji Pharma International
  - 26.2.11.1. Overview
  - 26.2.11.2. Product Portfolio
  - 26.2.11.3. Sales Footprint
  - 26.2.11.4. Key Developments
  - 26.2.11.5. Strategy Overview
- 26.2.12. Hetero Healthcare Limited
  - 26.2.12.1. Overview
  - 26.2.12.2. Product Portfolio
  - 26.2.12.3. Sales Footprint
  - 26.2.12.4. Key Developments
  - 26.2.12.5. Strategy Overview
- 26.2.13. Creative Enzymes
  - 26.2.13.1. Overview
  - 26.2.13.2. Product Portfolio
  - 26.2.13.3. Sales Footprint
  - 26.2.13.4. Key Developments
  - 26.2.13.5. Strategy Overview
- 26.2.14. Baoding Faithful Industry Co. Ltd.
  - 26.2.14.1. Overview
  - 26.2.14.2. Product Portfolio
  - 26.2.14.3. Sales Footprint
  - 26.2.14.4. Key Developments
  - 26.2.14.5. Strategy Overview
- 26.2.15. SG Pharma Pvt. Ltd.
  - 26.2.15.1. Overview
  - 26.2.15.2. Product Portfolio
  - 26.2.15.3. Sales Footprint
  - 26.2.15.4. Key Developments
  - 26.2.15.5. Strategy Overview
- 26.2.16. Provita Nutrition and Health Inc.
  - 26.2.16.1. Overview
  - 26.2.16.2. Product Portfolio
  - 26.2.16.3. Sales Footprint
  - 26.2.16.4. Key Developments
  - 26.2.16.5. Strategy Overview
- 26.2.17. Hepalink Group
  - 26.2.17.1. Overview
  - 26.2.17.2. Product Portfolio
  - 26.2.17.3. Sales Footprint
  - 26.2.17.4. Key Developments
  - 26.2.17.5. Strategy Overview
- 26.2.18. NOW(R) Foods
  - 26.2.18.1. Overview
  - 26.2.18.2. Product Portfolio
  - 26.2.18.3. Sales Footprint
  - 26.2.18.4. Key Developments
  - 26.2.18.5. Strategy Overview
- 26.2.19. Bio Basic Inc.
  - 26.2.19.1. Overview
  - 26.2.19.2. Product Portfolio
  - 26.2.19.3. Sales Footprint
  - 26.2.19.4. Key Developments
  - 26.2.19.5. Strategy Overview
- 26.2.20. Sichuan Deebio Pharmaceutical Co., Ltd.
  - 26.2.20.1. Overview
  - 26.2.20.2. Product Portfolio
  - 26.2.20.3. Sales Footprint
  - 26.2.20.4. Key Developments
  - 26.2.20.5. Strategy Overview
- 26.2.21. Others (Available on Request)
  - 26.2.21.1. Overview
  - 26.2.21.2. Product Portfolio
  - 26.2.21.3. Sales Footprint
  - 26.2.21.4. Key Developments
  - 26.2.21.5. Strategy Overview